

Advisory Board

The Tsinghua School of Pharmaceutical Sciences (SPS) Advisory Board was established in 2017 to provide strategic guidance and development support to SPS with an aim to build a world-class research and educational institute, and enhance Tsinghua’s global impact in the field of biomedical research and pharmaceutical innovation.
The Advisory Board consists of members who are renowned scientists and educators, outstanding healthcare business leaders and investors, state leaders and government officials as well as distinguished individuals and philanthropists. By building a platform among the academia, industry, government, NGOs and philanthropists worldwide, the Advisory Board provides valuable opinions and advices on healthcare issues of public interest as well as national and global importance. The Advisory Board will hold a series of activities including annual board meeting, forums, seminars that involve Tsinghua faculties, students, alumni and leaders from all sectors.
Board Members

As of January 2018, members of the Advisory Board include (a growing list):
-
Gerald Chan
Chairman and CEO
Morningside Group -
Feng Deng
Founding Managing Director
Northern Light Venture Capital -
Joaquin Duato
Executive Vice President and Worldwide
Chairman, Pharmaceuticals
Johnson & Johnson -
Yasuchika Hasegawa
Corporate Counselor
Former Chairman of the Board, and CEO
Takeda -
Anthony C. Hooper
Amgen
Executive Vice President, Global Commercial Operations -
Lars Fruergaard Jørgensen
President and CEO
Novo Nordisk -
Brian K. Kobilka
Professor of Molecular and Cellular Physiology
Stanford University School of Medicine
Nobel Laureate in Chemistry (2012) -
Peter Loescher
Former CEO, Siemens
Former President, Global Human Health, Merck & Co -
Ge Li
Founder, Chairman and CEO
WuXi AppTec -
Robert W. Mahley
Founding President and President Emeritus
Gladstone Institutes
Member of National Academy of Sciences, USA
Member of National Academy of Medicine, USA -
Robert T. Nelsen
Co-founder and Managing Director
ARCH Venture Partners -
Joerg Reinhardt
Chairman of the Board
Novartis -
Peter G. Schultz
Vice Chair of the Board and CEO
The Scripps Research Institute
Member of National Academy of Sciences, USA
Member of National Academy of Medicine, USA -
Neil Shen
Global Steward, Sequoia Capital
Founder and Managing Partner, Sequoia Capital China -
Stefan Oschmann
Chairman of the Executive Board and CEO of Merck
-
Yigong Shi
President
Westlake University
Member of Chinese Academy of Sciences
Foreign Member of National Academy of Sciences, USA -
Michel Vounatsos
CEO
Biogen -
Michael Goettler
Viatris
Chief Executive Officer -
WANG Xiqin
Vice President, Tsinghua University